Antibiogo: facts and impacts in the fight against antimicrobial resistance
The World Health Organization's Global AMR Awareness Week is a worldwide campaign to raise awareness and understanding of the problem of antimicrobial resistance. To mark the occasion, here is a series of infographics to help you better understand the hope that Antibiogo, a new diagnostic tool holds for combating this threat on public health.
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
The MSF Foundation is innovating by adapting a tool to help healthcare workers manage diabetic ketoacidosis, a severe acute complication in children with diabetes.
In 2025, the Antibiogo application is seeing wide deployment, extending beyond MSF field operations. After being adopted by all MSF laboratories in 2024, the tool has also been integrated...
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial